These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 5654242)

  • 21. [Differential diagnosis of arteriosclerosis obliterans and thromboangiitis obliterans].
    Emmrich R
    Z Gesamte Inn Med; 1973 Jul; 28(13):389-94. PubMed ID: 4804902
    [No Abstract]   [Full Text] [Related]  

  • 22. [Contribution to the study of internal temperatures in subjects with arterial diseases with obliterating evolution. II. Effects of venous administration of papaverine hydrochloride].
    Blasi A; Licciardello M
    Boll Soc Ital Cardiol; 1966; 11(4):1116-9. PubMed ID: 5992025
    [No Abstract]   [Full Text] [Related]  

  • 23. [Role of gangliectomy in the combined treatment of thrombotic obliterating diseases of the extremity arteries].
    Omeliashko AA; Shevchuk MG; Prokopyshin MV; Shabat IP; Slobodian MD
    Klin Khir (1962); 1981 Jul; (7):45-7. PubMed ID: 7277988
    [No Abstract]   [Full Text] [Related]  

  • 24. [Research on skin temperature and internal temperature in subjects with obliterating arteriopathy. Action of the association of kallikrein and meso-inositol hexanicotinate].
    Blasi A; Licciardello M
    Clin Ter; 1966 Oct; 39(1):33-8. PubMed ID: 5998855
    [No Abstract]   [Full Text] [Related]  

  • 25. [CLINICAL OBSERVATIONS ON THE USE OF GRISEOFULVIN IN CHRONIC PERIPHERAL OBLITERATING ARTERY DISEASES].
    SFORZA F; MOSSA L
    Rass Med Sarda; 1964; 67():555-78. PubMed ID: 14269114
    [No Abstract]   [Full Text] [Related]  

  • 26. Autoantibodies in thromboangiitis obliterans (Buerger's disease).
    Gulati SM; Madhra K; Thusoo TK; Nair SK; Saha K
    Angiology; 1982 Oct; 33(10):642-51. PubMed ID: 6751163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Therapeutic properties of xanthine nicotinate in the treatment of obliterating arteriopathies].
    Tardito E; Azzolini A; De Cristofaro A; Papacharalambus D
    Minerva Cardioangiol; 1972; 20(7):369-89. PubMed ID: 5050745
    [No Abstract]   [Full Text] [Related]  

  • 28. [Structural and histochemical changes of the gastrocnemius muscle in thrombo-obliterating diseases of the lower extremities].
    Turevskiĭ AA; Matsiuk IaR; Karpik AI
    Vestn Khir Im I I Grek; 1973 Nov; 111(11):67-73. PubMed ID: 4776335
    [No Abstract]   [Full Text] [Related]  

  • 29. Haematological differences between thromboangiitis obliterans and atherosclerosis.
    Craven JL; Cotton RC
    Br J Surg; 1967 Oct; 54(10):862-7. PubMed ID: 6047270
    [No Abstract]   [Full Text] [Related]  

  • 30. [REMOTE RESULTS OF TREATMENT OF PATIENTS WITH OBLITERATING ARTERIAL DISEASE].
    MAZURIK MF
    Khirurgiia (Mosk); 1963 Nov; 39():98-102. PubMed ID: 14141041
    [No Abstract]   [Full Text] [Related]  

  • 31. [Hemosorption in the treatment of occlusive arterial diseases of the legs].
    Korneev AA; Petukhov EB; Rodionov SV
    Vestn Khir Im I I Grek; 1988 Jul; 141(7):60-2. PubMed ID: 3222899
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Study of anti-neutrophil cytoplasmic antibodies in patients with thromboangiitis obliterans (Buerger's disease).
    Halacheva KS; Manolova IM; Petkov DP; Andreev AP
    Scand J Immunol; 1998 Nov; 48(5):544-50. PubMed ID: 9822265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Taurine in the therapy of obliterating arteriopathy of the lower extremities. I. Clinical results in various evolutive phases].
    Zanelli G; Ferrero S; Patrone P
    Minerva Cardioangiol; 1971 Nov; 19(11):605-15. PubMed ID: 5128422
    [No Abstract]   [Full Text] [Related]  

  • 34. [Further studies of the incidence of coronary cardiopathy in subjects with peripheral arteriosclerotic obliterating arteriopathy. Clinico-statistical investigations of 1434 cases].
    Meciani L; Ricci G; Boeri S; Sabatini G; Biasi G; Biglioli P
    Minerva Cardioangiol; 1971 Mar; 19(3):147-51. PubMed ID: 5553463
    [No Abstract]   [Full Text] [Related]  

  • 35. [Microwave therapy for patients with obliterating diseases of the peripheral vessels].
    Nikolaeva VV
    Vopr Kurortol Fizioter Lech Fiz Kult; 1971; 36(6):496-502. PubMed ID: 5140391
    [No Abstract]   [Full Text] [Related]  

  • 36. [Contribution to the study of internal temperatures in subjects with arterial diseases with obliterating evolution. I. Effects of sodium nicotinate, theophylline-ethylenediamine and theophylline nicotinate].
    Blasi A; Licciardello M
    Boll Soc Ital Cardiol; 1966; 11(4):1111-5. PubMed ID: 5992024
    [No Abstract]   [Full Text] [Related]  

  • 37. Thromboangiitis obliterans and arteriosclerosis obliterans.
    Ishikawa K
    Naika; 1965 Feb; 15(2):257-62. PubMed ID: 5833515
    [No Abstract]   [Full Text] [Related]  

  • 38. [Thromboangiitis obliterans (Buerger's disease). Study of 41 cases].
    Fernández-Miranda C; Rubio R; Vicario JL; Arnaiz A; Fernández Sáez R; Mollejo M; Pulido F; del Palacio A; Lázaro T
    Med Clin (Barc); 1993 Sep; 101(9):321-6. PubMed ID: 8412397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pathogenetic diagnosis of obliterating endarteritis].
    TSUKERMAN MA; VEKSLER IaI
    Voen Med Zh; 1959 Jan; 86(1):56-63. PubMed ID: 13648063
    [No Abstract]   [Full Text] [Related]  

  • 40. [Use of a new sympatholytic drug in therapy of chronic peripheral obliterating artery diseases].
    Vittori C; Taborelli G; Taborelli R
    Minerva Cardioangiol; 1965 Sep; 13(9):585-91. PubMed ID: 5851172
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.